Filing Details
- Accession Number:
- 0001237899-12-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-27 11:10:48
- Reporting Period:
- 2012-07-25
- Filing Date:
- 2012-07-27
- Accepted Time:
- 2012-07-27 11:10:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1377247 | Peter Powchik | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Clinical Development & Reg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-25 | 15,000 | $16.80 | 30,144 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-25 | 1,987 | $126.76 | 28,157 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-07-25 | 5,994 | $126.76 | 22,163 | No | 4 | F | Direct | |
Common Stock | Disposition | 2012-07-26 | 4,519 | $130.40 | 17,644 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-26 | 2,500 | $131.07 | 15,144 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-07-25 | 15,000 | $0.00 | 15,000 | $16.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | 2011-12-17 | 2018-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,532 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 4,519 shares of Company stock on July 26, 2012 at prices ranging from $130.21 to $130.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price.
- Represents volume-weighted average price of sales of 2,500 shares of Company stock on July 26, 2012 at prices ranging from $131.05 to $131.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price.
- On December 17, 2008, the reporting person was granted an option to purchase 30,000 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.